OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 99 filers reported holding OPHTHOTECH CORP in Q1 2017. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,230,000 | +252.5% | 3,000,000 | +200.0% | 1.68% | +243.4% |
| Q4 2018 | $1,200,000 | -49.2% | 1,000,000 | 0.0% | 0.49% | -27.4% |
| Q3 2018 | $2,360,000 | -6.5% | 1,000,000 | +8.1% | 0.67% | -20.2% |
| Q2 2018 | $2,525,000 | +8.6% | 925,000 | +9.0% | 0.84% | -23.6% |
| Q1 2018 | $2,326,000 | -0.6% | 848,840 | +13.2% | 1.11% | -13.4% |
| Q4 2017 | $2,340,000 | +7.0% | 750,000 | -3.2% | 1.28% | -4.6% |
| Q3 2017 | $2,186,000 | +36.6% | 775,000 | +24.0% | 1.34% | +43.3% |
| Q2 2017 | $1,600,000 | -7.2% | 625,000 | +32.7% | 0.93% | -13.3% |
| Q1 2017 | $1,724,000 | – | 471,149 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,053,143 | $95,533,000 | 31.57% |
| Clarus Ventures, LLC | 1,554,744 | $72,342,000 | 30.07% |
| Novo Holdings A/S | 4,910,487 | $228,485,000 | 19.43% |
| JHL Capital Group LLC | 3,265,000 | $151,920,000 | 13.98% |
| AlpInvest Partners B.V. | 37,500 | $1,745,000 | 3.26% |
| Opaleye Management Inc. | 105,000 | $4,886,000 | 2.27% |
| IMA Wealth, Inc. | 67,930 | $3,161,000 | 1.54% |
| Hillview Capital Advisors, LLC | 34,830 | $1,621,000 | 1.40% |
| Cheyne Capital Management (UK) LLP | 124,151 | $5,777,000 | 1.39% |
| WILLIAM HARRIS INVESTORS INC | 106,158 | $4,939,000 | 1.30% |